Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes

Figure 4

Mammary extracellular matrix (ECM) proteolysis is reduced with tamoxifen treatment. (a) Western blot analyses of fibronectin, laminin 1 and laminin 5 in mammary tissue from control and tamoxifen-treated rats, with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as loading control. (b) Fibrillar collagen detected by Western blot (left panel) and in 5 μm Picro-sirius red stained mammary gland sections. (c) Matrix metalloproteinase (MMP) 2 activity detected by zymography, with total MMP-2 levels and active MMP-2 levels quantified by scanning densitometry (*p = 0.005 and *p < 0.0001, respectively).

Back to article page